(IN BRIEF) EIB is providing up to €37.5 million in venture debt to Xeltis as part of a new €50 million financing package that will help bring aXess, the company’s regenerative vascular access conduit, to market. The investment follows excellent … Read the full press release
Posted in Banks, Energy, Gas & Oil, European Union, Financial, Healthcare, Infrastructure & Utilities, Investment, Luxembourg, Netherlands, News, Pharma & Biotech
Tagged Alexander Goemans, aXess, commercialization funding, EIB, Eliane Schutte, end stage renal disease, Endogenous Tissue Restoration, EQT Life Sciences, ETR platform, EU pivotal trial, European Investment Bank, hemodialysis, Invest-NL, InvestEU, LSP Health Economics Fund 2, MedTech innovation, PFAS free polymer technology, regenerative implants, Robert de Groot, US pivotal trial, vascular access conduit, venture-debt financing, Xabg, Xeltis, Xeltis Advances Regenerative Implant Portfolio with Strong Backing from EIB and Existing Investors
(IN BRIEF) The European Investment Bank (EIB) has awarded Belgium-based medtech company Nyxoah €37.5 million in venture-debt financing to support the development of innovative treatments for obstructive sleep apnea (OSA). This funding, backed by the InvestEU Life Sciences programme, will … Read the full press release
Posted in Banks, Belgium, European Union, Financial, Healthcare, Pharma & Biotech
Tagged Belgium, commercialization, EIB, equity offering, Europe, European Investment Bank, financing, Genio system, hypoglossal neurostimulation therapy, INNOVATION, InvestEU, InvestEU Life Sciences programme, life sciences, manufacturing capacity, medtech, Nyxoah, obstructive sleep apnea, Olivier Taelman, OSA, production capacity, research and development, Robert de Groot, technological innovation, US, venture-debt financing
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?